Efficacy of MEK inhibition in a recurrent malignant peripheral nerve sheath tumor
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy of MEK inhibition in a recurrent malignant peripheral nerve sheath tumor
Authors
Keywords
-
Journal
npj Precision Oncology
Volume 5, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-12
DOI
10.1038/s41698-021-00145-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- RABL6A is an essential driver of MPNSTs that negatively regulates the RB1 pathway and sensitizes tumor cells to CDK4/6 inhibitors
- (2020) Jordan L Kohlmeyer et al. CLINICAL CANCER RESEARCH
- Selumetinib in Children with Inoperable Plexiform Neurofibromas
- (2020) Andrea M. Gross et al. NEW ENGLAND JOURNAL OF MEDICINE
- Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer
- (2020) Marie Wong et al. NATURE MEDICINE
- H3K27 trimethylation loss in malignant peripheral nerve sheath tumor: a systematic review and meta-analysis with diagnostic implications
- (2019) Victor M. Lu et al. JOURNAL OF NEURO-ONCOLOGY
- Outcome and prognostic factors in pediatric malignant peripheral nerve sheath tumors: An analysis of the European Pediatric Soft Tissue Sarcoma Group (EpSSG) NRSTS-2005 prospective study
- (2019) Max M. van Noesel et al. PEDIATRIC BLOOD & CANCER
- Neurofibromin level directs RAS pathway signaling and mediates sensitivity to targeted agents in malignant peripheral nerve sheath tumors
- (2018) Elliot John Kahen et al. Oncotarget
- Trametinib in pediatric patients with neurofibromatosis type 1 (NF-1)–associated plexiform neurofibroma: A phase I/IIa study.
- (2018) Geoffrey Brian McCowage et al. JOURNAL OF CLINICAL ONCOLOGY
- Trametinib for progressive pediatric low-grade gliomas
- (2018) Maria Kondyli et al. JOURNAL OF NEURO-ONCOLOGY
- Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1–associated, and radiation-associated malignant peripheral nerve sheath tumors
- (2017) Kelsey L. Watson et al. JOURNAL OF NEUROSURGERY
- Report of effective trametinib therapy in 2 children with progressive hypothalamic optic pathway pilocytic astrocytoma: documentation of volumetric response
- (2017) Catherine Miller et al. Journal of Neurosurgery-Pediatrics
- The NF1 gene in tumor syndromes and melanoma
- (2017) Maija Kiuru et al. LABORATORY INVESTIGATION
- Salvage rates and prognostic factors after relapse in children and adolescents with malignant peripheral nerve sheath tumors
- (2017) Luca Bergamaschi et al. PEDIATRIC BLOOD & CANCER
- The genomic landscape of malignant peripheral nerve sheath tumors: diverse drivers of Ras pathway activation
- (2017) Andrew S. Brohl et al. Scientific Reports
- Erratum: Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival
- (2016) Arjen HG Cleven et al. MODERN PATHOLOGY
- Activity of Selumetinib in Neurofibromatosis Type 1–Related Plexiform Neurofibromas
- (2016) Eva Dombi et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARC009: Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced sarcoma
- (2015) Scott M. Schuetze et al. CANCER
- RAS-MAPK in ALK targeted therapy resistance
- (2015) Gorjan Hrustanovic et al. CELL CYCLE
- Efficacy of CDK4 inhibition against sarcomas depends on their levels of CDK4 and p16ink4 mRNA
- (2015) Marco Perez et al. Oncotarget
- The NF1 gene revisited – from bench to bedside
- (2015) Yoon-Sim Yap et al. Oncotarget
- PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies
- (2014) Thomas De Raedt et al. NATURE
- PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors
- (2014) William Lee et al. NATURE GENETICS
- EGFR–STAT3 signaling promotes formation of malignant peripheral nerve sheath tumors
- (2013) J Wu et al. ONCOGENE
- MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors
- (2012) Walter J. Jessen et al. JOURNAL OF CLINICAL INVESTIGATION
- Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1
- (2012) M. Kolberg et al. NEURO-ONCOLOGY
- Phase II Multicenter Trial of Imatinib in 10 Histologic Subtypes of Sarcoma Using a Bayesian Hierarchical Statistical Model
- (2009) Rashmi Chugh et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas
- (2009) Robert G. Maki et al. JOURNAL OF CLINICAL ONCOLOGY
- EGFR and erbB2 in malignant peripheral nerve sheath tumors and implications for targeted therapy
- (2008) Nikola Holtkamp et al. NEURO-ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now